<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
<channel>
<title>Brain Waves</title>
<link>/home/corante/public_html/brainwaves/</link>
<description>The field of neurotechnology, the focus of this blog, encompasses advances in brain science (neurons), information technology (bits) and bioengineering (genes).  Up for discussion and analysis: the political, economic, ethical, and social forces that will shape the future of what will be one of the most important and fascinating stories of the coming decades. </description>
<copyright>Copyright 2008</copyright>
<lastBuildDate>Fri, 28 Nov 2008 15:08:11 -0500</lastBuildDate>
<generator>http://www.movabletype.org/?v=3.34</generator>
<docs>http://blogs.law.harvard.edu/tech/rss</docs> 

<item>
<title>Global Neurosecurity Discussions Needed</title>
<description><![CDATA[<p><img alt="neuronss.png" src="http://brainwaves.corante.com/neuronss.png" width="90" height="50" />Jonathan Moreno writes another insightful piece, <a href="http://www.scienceprogress.org/2008/11/intelligence-on-the-brain/">Intelligence on the Brain</a> which discusses the need for a new dialogue on neuroresearch and national security.  </p>]]></description>
<link>http://brainwaves.corante.com/archives/2008/11/28/global_neurosecurity_discussions_needed.php</link>
<guid>http://brainwaves.corante.com/archives/2008/11/28/global_neurosecurity_discussions_needed.php</guid>
<category>Neurosociety</category>
<pubDate>Fri, 28 Nov 2008 15:08:11 -0500</pubDate>
</item>
<item>
<title>Neuroscience Summer Boot Camp 2009 for Non-Scientists, Aug. 2-12</title>
<description><![CDATA[<p><img alt="PennBoot.png" src="http://brainwaves.corante.com/PennBoot.png" width="170" height="80" />Neuroscience is increasingly relevant to a number of professions and academic disciplines beyond its traditional medical applications. Indeed, for any field in which it is important to understand, predict or influence human behavior, neuroscience will play an increasing role. The <a href="http://neuroethics.upenn.edu/boot_camp.html">Penn Neuroscience Boot Camp</a> is designed to give participants a basic foundation in cognitive and affective neuroscience and to equip them to be informed consumers of neuroscience research. <strong>The Boot Camp faculty consists of leaders in the fields of cognitive and affective neuroscience who are committed to the goal of educating non-neuroscientists</strong>. </p>

<p><strong>Lawyers, educators, economists and businesspeople, as well as scholars of sociology, philosophy, applied ethics and policy</strong>, are incorporating the concepts and methods of neuroscience into their work. Graduate and professional students, working professionals and college and university faculty are encouraged to apply. The only prerequisites are a grasp of basic statistics and at least a dim recollection of high school biology and physics. (A short set of readings will be made available prior to the Boot Camp to remind you about the essentials.) <em>Participants will be housed on campus in air-conditioned apartment-style suites with private bedrooms. </em></p>]]></description>
<link>http://brainwaves.corante.com/archives/2008/11/26/neuroscience_summer_boot_camp_2009_for_nonscientists_aug_212.php</link>
<guid>http://brainwaves.corante.com/archives/2008/11/26/neuroscience_summer_boot_camp_2009_for_nonscientists_aug_212.php</guid>
<category>Neuroethics</category>
<pubDate>Wed, 26 Nov 2008 13:44:13 -0500</pubDate>
</item>
<item>
<title>NIO Unveils Top 10 Neuroscience Trends for 2009</title>
<description><![CDATA[<p><img alt="top10.png" src="http://brainwaves.corante.com/top10.png" width="126" height="106" />Here are ten emerging areas of neuroscience that will impact the future of treatments for brain and nervous system which were published as a result of the cutting edge research being presented at the Society for Neuroscience Conference held in Washington DC last week. Top 10 Trends of 2009:<br />
<strong><br />
1.    Epigenetics leading to new treatment targets: </strong>New research highlights the critical interactions of genes and the environment in brain health and development revealing new treatment strategies and potential therapeutic targets for obesity, memory loss, addiction and mental illness.</p>

<p><strong>2.    National Neurotechnology Initiative Act:</strong> Momentum for this recently introduced legislation which provides $200M a year for federal R&D aimed at accelerating translational neurotech innovation and improving the effectiveness of FDA review process for neuroscience drugs, devices and diagnostics grows.<br />
<strong><br />
3.     New Sources of Stem Cells: </strong>The discovery of new sources of neural stem cells are opening up new avenues and potentially whole new treatment strategies for stroke, vision loss, hearing loss, Parkinson’s, Alzheimer’s, and ALS.</p>

<p><strong>4.     Deep Brain Stimulation: </strong> New clinical research into the use of deep brain stimulation devices for the treatment of neurological diseases and psychiatric illnesses continues to provide new hope to those suffering from drug treatment forms of these illnesses. </p>

<p><strong>5.    Addiction advances: </strong>New research that clarifies the role of impulsivity in treating cocaine addiction and synaptic plasticity in the control of inhibitory circuits could potentially lead to new treatment strategies for this epidemic impacting over 1.1 billion worldwide.</p>

<p><strong>6.     Stress prevention:</strong> New research shows that even a few hours of stress can reduce neural connectivity and that chronic stress, in particular early in life, can shrink critical areas of the brain. These findings may lead to new treatment strategies for PTSD and other anxiety-related disorders.</p>

<p><strong>7.    Traumatic brain injury advances:</strong> Early detection proves important for effective treatment while new research into inflammation may provide new treatments for people with brain injuries and stroke.</p>

<p><strong>8.     Get your sleep: </strong>More research points to the critical role that a proper night’s sleep plays in the memory consolidation, learning and mental illness further validating the need for effective therapeutics which engender healthy sleep patterns.</p>

<p><strong>9.   Discovery tools underpin innovation: </strong>New imaging techniques coupled with advances in neuroinformatics, image-based neural circuit analysis, and neural computation are accelerating the pace of neuroscientific discovery beyond what was imagined a decade ago.</p>

<p><strong>10.    Neuroscience infiltrates society:</strong> From neurofinance, neuroeconomics to neuroesthetics to neuroethics and neurolaw, the influence of neuroscience on society continues to grow. </p>]]></description>
<link>http://brainwaves.corante.com/archives/2008/11/25/nio_unveils_top_10_neuroscience_trends_for_2009.php</link>
<guid>http://brainwaves.corante.com/archives/2008/11/25/nio_unveils_top_10_neuroscience_trends_for_2009.php</guid>
<category>Neurotech Industry</category>
<pubDate>Tue, 25 Nov 2008 15:07:07 -0500</pubDate>
</item>
<item>
<title>NIO CEO Media Tour in NYC Gets Results</title>
<description><![CDATA[<p><img alt="WSJ.png" src="http://brainwaves.corante.com/WSJ.png" width="212" height="35" />Yesterday, I hosted NIO's annual public neurotech company CEO media tour here in NYC with Uli Hacksell, CEO of <a href="http://www.acadia-pharm.com/">Acadia Pharmaceuticals</a>, Ron Cohen, CEO of <a href="http://www.acorda.com/">Acorda Therapeutics</a> and Joern Aldag, CEO of <a href="http://www.evotec.com/en/">Evotec</a> joining me in hour long discussions with reporters at the Wall Street Journal, BusinessWeek, PharmaWire (Financial Times), Discover Magazine, and Forbes.  The discussions were lively and revolved around the impact of the current financial crisis as well as the lack of adequate regulatory resources.  The Wall Street Journal picked up on our conversation and posted some of it on the WSJ Health Blog: <a href="http://blogs.wsj.com/health/2008/11/10/fda-delays-take-toll-on-neuroscience-drug-development/">FDA Delays Take Toll on Neuroscience Drug Development</a>posted by Shirley S. Wang. </p>

<p>"The FDA has even the neuroscience crowd scratching their heads.</p>

<p>Some folks from the <a href="http://www.neurotechindustry.org/">Neurotechnology Industry Organization</a>, a trade group for neuroscience companies, and three of its members stopped by Health Blog HQ today. Our chat really heated up when it turned to the current regulatory environment...(<a href="http://blogs.wsj.com/health/2008/11/10/fda-delays-take-toll-on-neuroscience-drug-development/">more</a>)</p>]]></description>
<link>http://brainwaves.corante.com/archives/2008/11/11/nio_ceo_media_tour_in_nyc_gets_results.php</link>
<guid>http://brainwaves.corante.com/archives/2008/11/11/nio_ceo_media_tour_in_nyc_gets_results.php</guid>
<category>Neurotech Industry</category>
<pubDate>Tue, 11 Nov 2008 07:52:49 -0500</pubDate>
</item>
<item>
<title>O Neurocaster</title>
<description><![CDATA[<p><img alt="Oprah.png" src="http://brainwaves.corante.com/Oprah.png" width="150" height="222" />O, The Oprah Magazine, has an article written by Tim Jarvis in the mindwise section this month titled, <a href="http://www.oprah.com/article/omagazine/200811_omag_brain">The Brain Age</a>. The article explores how "cutting-edge neuroscience has escaped from the lab and is suddenly showing up everywhere, changing the way we practice law, go shopping and possibly, fall in love.  Tim interviewed me extensively for the article over a year ago and it's nice to see it finally his the newstand in the November issue.  In a side bar, Tim asked me to forecast some neuroscientific advancements that would ring with O readers, here are a few I posit:</p>

<p><strong>Neuroentertainment: </strong> Current technologies such as video games will merge with future one (such as those involving neural feedback) so gamers might wear EEG-type caps that read their brainwaves and pick up their emotions.  Conceivably, story lines would move forward in real time, the plot changing based on each person's response, says Zack Lynch.</p>

<p><strong>Neuroeducation:</strong> The more we learn about the neurobiology of learning - how the mind develops, what to make of differences between individual brains - the better we can "sculpt" teaching methods. Lynch predicts educational software will be tailored to students' individual brain patterns to improve math and language acquisition as well as creative thinking.</p>

<p><strong>Neurospirituality: </strong>New tools such as real-time FMRI technology, Lynch says, promise to accelerate our capacity to access deeply meditative and spiritual states.</p>

<p>Check out <a href="http://www.oprah.com/article/omagazine/200811_omag_brain">the article</a> as it scans several areas of the neurosociety.</p>]]></description>
<link>http://brainwaves.corante.com/archives/2008/11/06/o_neurocaster.php</link>
<guid>http://brainwaves.corante.com/archives/2008/11/06/o_neurocaster.php</guid>
<category>Neurosociety</category>
<pubDate>Thu, 06 Nov 2008 14:38:42 -0500</pubDate>
</item>
<item>
<title>Manuscript Sent to Japan</title>
<description><![CDATA[<p><img alt="cov.png" src="http://brainwaves.corante.com/cov.png" width="107" height="73" />Where do I start? It's been an amazing journey, but the book I've been working on for the past eight years is finally off the type setter at St. Martin's Press.  Moreover, this morning I sent the manuscript off to my publisher in Japan. So if you have been wondering why the blog posting has been so slow the past couple of months, or more like over the past year, this is why. I've been heads down in the future. I'm looking forward to announcing the title of the book a little bit further down, but let me just say, it's pretty cool. Of course, I'm biased, so you'll have to let me know once it hits the book stores, which right now looks like June 2009. I know, an infinite amount of time.  </p>]]></description>
<link>http://brainwaves.corante.com/archives/2008/10/28/manuscript_sent_to_japan.php</link>
<guid>http://brainwaves.corante.com/archives/2008/10/28/manuscript_sent_to_japan.php</guid>
<category>Neurosociety</category>
<pubDate>Tue, 28 Oct 2008 15:53:28 -0500</pubDate>
</item>
<item>
<title>2009 Stem Cell Trendsetters in Neurology and Psychiatry</title>
<description><![CDATA[<p><img alt="120_Stem_Cell_Report_Cover_120.jpg" src="http://brainwaves.corante.com/120_Stem_Cell_Report_Cover_120.jpg" width="120" height="155" />Stem cell approaches in neurology and psychiatry is the focus of a new report released today by <a href="http://www.neuroinsights.com/home.html">NeuroInsights</a>, the neurotech market authority. The industry insider report on innovative research and development in stem cell technology for the brain and nervous system provides unique insights into the key players and competitive dynamics in this rapidly evolving field.</p>

<p>Stem cell companies focused on the central nervous system (CNS) have the potential to address some of the largest unmet healthcare markets including: Alzheimer's disease, amyotrophic lateral sclerosis, depression, hearing loss, Huntington's disease, lysosomal storage disorders, multiple sclerosis, Parkinson's disease, retinal disorders, spinal cord injury, stroke, traumatic brain injury, and other brain and nervous system disorders.</p>

<p>The report analyzes the scientific approaches and challenges to utilizing stem cells in the CNS, discusses trends and drivers including funding and regulatory issues, reveals promising treatment indications and pipelines, examines business models leveraging the promise of stem cells, and sheds light on investment opportunities and risks. It provides in-depth profiles of twenty seven companies that are shaping the field and spearheading the use of stem cells in the brain and nervous system.</p>

<p>The twenty seven trend setting companies reviewed in the report include: Aastrom Biosciences, Advanced Cell Technology, ArunA Biomedical, Athersys (Nasdaq: ATHX), Beike Biotechnology Company, BrainCells, Inc., BrainStorm Cell Therapeutics, California Stem Cell Inc., Cell Cure Neurosciences, CellMed AG, Geron Corporation (Nasdaq: GERN), International Stem Cell Corporation, NeuralStem, NeuroGeneration, NeuroNascent, NeuroNova AB, Neuronyx, NsGene A/S, Pfizer Regenerative Medicine, Q Therapeutics, ReNeuron Group (LSE: RENE.L), RhinoCyte, Stem Cell Sciences (LSE: STEM.L), Stem Cell Therapeutics (TSX: SSS.V), Stem Cell Technologies, StemCells, Inc. (Nasdaq: STEM), and Theradigm, Inc.</p>

<p>The 175 page report, "<a href="http://www.neuroinsights.com/marketreports/stemcellreport.html">Stem Cell Approaches in Neurology and Psychiatry: 27 Trendsetters for 2009</a>" is available immediately.</p>]]></description>
<link>http://brainwaves.corante.com/archives/2008/10/15/2009_stem_cell_trendsetters_in_neurology_and_psychiatry.php</link>
<guid>http://brainwaves.corante.com/archives/2008/10/15/2009_stem_cell_trendsetters_in_neurology_and_psychiatry.php</guid>
<category>Neurotech Industry</category>
<pubDate>Wed, 15 Oct 2008 10:07:24 -0500</pubDate>
</item>
<item>
<title>Mental Health Parity Legislation Passes within Financial Package</title>
<description><![CDATA[<p><img alt="160px-Paul_Wellstone%2C_official_Senate_photo_portrait.jpg" src="http://brainwaves.corante.com/160px-Paul_Wellstone%2C_official_Senate_photo_portrait.jpg" width="80" height="103" />The House of Representatives, moments ago, voted to approve, by a vote of 263 to 171, the Emergency Economic Stabilization Act (H.R. 1424), which includes a new financial rescue bill, tax extenders package and mental health and substance use disorder parity legislation, the <a href="http://www.govtrack.us/congress/bill.xpd?bill=h110-6983">Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008</a> (introduced as H.R. 6983).  The same package cleared the Senate on October 1 by a vote of 74 to 25.  The bill will now be sent to the White House where the President is expected to sign the legislation.<br />
 <br />
During the House floor debate, a number of those in support of the package applauded the work of Rep. Patrick Kennedy (D-RI) and Rep. Jim Ramstad (R-MN), the lead sponsors of the parity bill, for their leadership.  In his floor statement, Rep. Kennedy celebrated passage of the parity bill and called on observers to remember the incredible life and contributions of the late <a href="http://en.wikipedia.org/wiki/Paul_Wellstone">Paul Wellstone</a>.  Leaders also recognized the tireless work of Senator Domenici (R-NM), a Senate champion who is retiring from public service this year, and Senator Kennedy (D-MA), another champion in the Senate, who is battling cancer.  Speaker Pelosi, in her floor statement before the vote, said of the House action, “We are helping to end discrimination” for those seeking treatment for substance use disorders. </p>]]></description>
<link>http://brainwaves.corante.com/archives/2008/10/03/mental_health_parity_legislation_passes_within_financial_package.php</link>
<guid>http://brainwaves.corante.com/archives/2008/10/03/mental_health_parity_legislation_passes_within_financial_package.php</guid>
<category>Mental Health Issues</category>
<pubDate>Fri, 03 Oct 2008 13:36:28 -0500</pubDate>
</item>
<item>
<title>Holy Neurofinancial Meltdown Bernanke</title>
<description><![CDATA[<p><img alt="forbes.png" src="http://brainwaves.corante.com/forbes.png" width="207" height="151" />Emotions are riding very high. Herd behavior is everywhere. And if you listen to Treasury Secretary Paulson and Fed Chief Bernanke the primary reason for such a high bailout amount of $700B is to inspire "confidence" in the market. So are our brains to blame for this market mess?  Yes, at least according leading neuroeconomist interviewed by Forbes Matthew Herper in his recent piece, <a href="http://www.forbes.com/home/2008/09/24/neuroscience-psycology-money-forbeslife-health-cx_mh_0924brain.html">Market Mess, Blame Your Brain</a>.</p>

<blockquote>"Fear plus herding equals panic," says Gregory Berns, a neuroeconomist at Emory University. "You bet it's biologically based." 

<p>At the core of the market mess are securities that were backed by extremely risky mortgages. The theory was that slicing and dicing mortgages diluted the risk away.</p>

<p>But the ratings agencies were being compensated by issuers of the mortgage-backed securities, and neuroeconomics says that created big problems. "You don't get mistakes this big based on stupidity alone," says George Loewenstein of Carnegie Mellon University. "It's when you combine stupidity and people's incentives that you get errors of this magnitude."</p>

<p>Consider this forthcoming research by Loewenstein, Roberto Weber and John Hamman, all of Carnegie Mellon. They organized volunteers into partners. One partner is given $10 and told to split it however he sees fit. On average, the deciding partner keeps $8 and gives away $2.</p>

<p>Then researchers repeat the game. This time, the decider pays an "analyst" to decide how to split the money fairly. The game continues for multiple rounds and the decider can fire the analyst. With this change, the decider gets everything. Paying somebody else to ensure assets are divided fairly actually makes things less fair.</blockquote></p>

<p>So what's a regulator to do? Read about that in <a href="http://www.forbes.com/home/2008/09/24/neuroscience-psycology-money-forbeslife-health-cx_mh_0924brain.html">Herper's full article here.</a></p>]]></description>
<link>http://brainwaves.corante.com/archives/2008/09/26/holy_neurofinancial_meltdown_bernanke.php</link>
<guid>http://brainwaves.corante.com/archives/2008/09/26/holy_neurofinancial_meltdown_bernanke.php</guid>
<category>Neurofinance</category>
<pubDate>Fri, 26 Sep 2008 14:20:07 -0500</pubDate>
</item>
<item>
<title>Interest in Neuropolicy Grows</title>
<description><![CDATA[<p><img alt="pd_brain_070428_mn.jpg" src="http://brainwaves.corante.com/pd_brain_070428_mn.jpg" width="120" height="90" />A new <a href="http://www.emory.edu/EMORY_REPORT/erarchive/2008/July/July21/Neuropolicy.htm">Center for Neuropolicy at Emory University</a> will focus on how the biology of the brain influences decision-making in politics, policy and business. As a partnership among researchers in the Emory School of Medicine, Emory College and the <a href="http://www.goizueta.emory.edu/">Goizueta Business School</a>, the center will create an ideal environment to accelerate discovery in this emerging field. The Center is the vision of <a href="http://www.ccnl.emory.edu/greg/">Gregory S. Berns, MD, PhD</a>, professor in the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine. Berns specializes in the use of brain imaging technologies to understand human motivation and decision-making, with a special interest in <a href="http://neuroeconomics.typepad.com/">neuroeconomics</a> and <a href="http://www.psych.nyu.edu/amodiolab/">social neuroscience</a>. There are a whole host of <a href="http://brainwaves.corante.com/archives/neuropolicy/">emerging neuropolicy issues</a> that need analyzing including: <a href="http://kolber.typepad.com/ethics_law_blog/">neurolaw</a>, <a href="http://www.neurosciencemarketing.com/blog/">neuromarketing</a> and <a href="http://brainwaves.corante.com/archives/2008/08/14/neurowarfare_futures_report_released.php">neurowarfare</a>.</p>]]></description>
<link>http://brainwaves.corante.com/archives/2008/09/05/interest_in_neuropolicy_grows.php</link>
<guid>http://brainwaves.corante.com/archives/2008/09/05/interest_in_neuropolicy_grows.php</guid>
<category>Neuropolicy</category>
<pubDate>Fri, 05 Sep 2008 11:33:35 -0500</pubDate>
</item>
<item>
<title>Want to Start a Neurotech Venture?</title>
<description><![CDATA[<p><img alt="NeurotechVenturesClass.png" src="http://brainwaves.corante.com/NeurotechVenturesClass.png" width="130" height="200" />Do you have what it takes to start your own neurotech venture?  If you think so, then I'd highly recommend getting over to MIT to enroll in this year's <a href="http://neuro.media.mit.edu/classes/neuroven/08.fa/">Neurotechnology Ventures seminar put on by Ed Boyden, Joost Paul Bonsen and Rutledge Ellis-Behnke</a>. Each 2-hour class begins with a survey of a broad topic area, and continues with a live-case study of a current, specific, development or commercialization effort in that area. Explorations will cover a broad array of issues ranging from the deeply technical, to the analysis of market realities from across <a href="http://www.neuroinsights.com/marketreports/marketreport2008.html">the neurotechology industry</a>. Topics Include: neuroimaging, neurology/psychiatry diagnosis, rehabilitation, neurosurgery, neuropharmacology, brain Stimulation, prosthetics, sensory and motor augmentation, regenerative neuromedicine, and more. I'll be back there next week for the kick off meeting giving an overview of the neurotech industry while following weeks are full of exciting emerging neurotech innovators. </p>]]></description>
<link>http://brainwaves.corante.com/archives/2008/09/02/want_to_start_a_neurotech_venture.php</link>
<guid>http://brainwaves.corante.com/archives/2008/09/02/want_to_start_a_neurotech_venture.php</guid>
<category>Neurotech Industry</category>
<pubDate>Tue, 02 Sep 2008 13:31:33 -0500</pubDate>
</item>
<item>
<title>Neurotech Innovation to be Analyzed</title>
<description><![CDATA[<p><img alt="Innova.png" src="http://brainwaves.corante.com/Innova.png" width="185" height="100" />Casey and I recently met up in SF with <a href="http://mitsloan.mit.edu/faculty/detail.php?in_spseqno=28713&co_list=F">Jason Davis</a>, Assistant Professor of Strategy in the MIT Sloan School of Management, to explore his <a href="http://web.mit.edu/neuroinnovation/">neurotech innovation project</a> whose goal is to understand what makes neurotechnology innovations and ventures successful. It's great to see a serious innovation strategy expert excited about analyzing the rapidly evolving neurotech economy.  </p>]]></description>
<link>http://brainwaves.corante.com/archives/2008/08/26/neurotech_innovation_to_be_analyzed.php</link>
<guid>http://brainwaves.corante.com/archives/2008/08/26/neurotech_innovation_to_be_analyzed.php</guid>
<category>Neurotech Industry</category>
<pubDate>Tue, 26 Aug 2008 10:35:38 -0500</pubDate>
</item>
<item>
<title>Governing Emerging Technologies Gordon Rearch Conference</title>
<description><![CDATA[<p><img alt="GRC.png" src="http://brainwaves.corante.com/GRC.png" width="73" height="79" />I just spent the past week in Big Sky Montana participating in a <a href="http://ieet.org/index.php/IEET/eventinfo/20080817gordon/">five day conference on governing emerging technologies</a>.  There was far too much to begin to cover here, but I have to give kudos to the organizers <a href="http://cspo.org/about/people/guston.htm">David Guston</a> and <a href="http://www.adelaide.edu.au/directory/rachel.ankeny">Rachel Ankeny</a> for bringing together a broad group of speakers and contributors from across the globe. Three key emerging techs highlighted throughout the conference were neurotech, <a href="http://syntheticbiology.org/">synthetic biology</a> and nanotech. </p>

<p><img alt="Lone%20Peak.jpg" src="http://brainwaves.corante.com/Lone%20Peak.jpg" width="155" height="101" />Overall, it seems that the science and technology policy community (including industry) has the most comprehensive grasp of current and future emergent issues pertaining to nanotech. Developing dilemmas related to synthetic biology and its applications in biowarfare and implications for global security pose an ongoing, vexing problem for S&T policy. S&T policy issues related to advancing neurotechnologies seemed most fragmented with little coherence on what can or should be done with respect to the development and application of these technologies beyond therapy. Rightly so, many participants were quite alarmed with what could be on the neurotech horizon in terms of "<a href="http://brainwaves.corante.com/archives/perception_shift/">perception shifting</a>", <a href="http://www.corante.com/brainwaves/archives/2004/09/16/neurolaw_the_scales_of_justice.php">neurolegal implications</a> and the squelching of <a href="http://www.innovationwatch.com/choiceisyours/choiceisyours-2007-04-30.htm">neurodiversity</a>. Several participants, especially LSE's <a href="http://www.lse.ac.uk/people/s.vrecko@lse.ac.uk/">Scott Vrecko</a> (who I met at last November's <a href="http://brainwaves.corante.com/archives/2007/11/08/neurosocieties_the_rise_and_impact_of_the_new_brain_sciences.php">Neurosocieties conference in London</a>), reminded the policy community to identity current issues in neuroscience rather than pondering "what ifs." That said, it was great to hear <a href="http://www.natashadowschull.org/">Natasha Schull</a>'s thoughts on the potential public policy implications of <a href="http://www.natashadowschull.org/">neuroeconomics research</a>, <a href="http://nanobio-raise.org/groups/writers/resumes/document.2006-02-09.0453161098">George Khushf</a>'s presentation on the ethical implication of neural implants and <a href="http://www.michaelchorost.com/">Mike Chorost</a>'s pontifications on the future of neurodevice development.</p>]]></description>
<link>http://brainwaves.corante.com/archives/2008/08/25/governing_emerging_technologies_gordon_rearch_conference.php</link>
<guid>http://brainwaves.corante.com/archives/2008/08/25/governing_emerging_technologies_gordon_rearch_conference.php</guid>
<category>Neuropolicy</category>
<pubDate>Mon, 25 Aug 2008 12:49:00 -0500</pubDate>
</item>
<item>
<title>Neurowarfare Futures Report Released</title>
<description><![CDATA[<p><img alt="no-brain-01.jpg" src="http://brainwaves.corante.com/no-brain-01.jpg" width="90" height="132" />Back in March of 2003, I blogged here <a href="http://brainwaves.corante.com/archives/2003/03/28/neurowarfare_a_nonlethal_second_chance.php">about neurowarfare</a> and how the latest national intelligence reports were completely missing the boat on <a href="http://www.corante.com/brainwaves/archives/2003/10/24/neurowar.php">neurowar</a>.  </p>

<p>It took a few years, but after Jonathan Moreno wrote <a href="http://www.amazon.com/Mind-Wars-Research-National-Defense/dp/1932594167">Mind Wars</a>, the US defense community woke up and put together a committee, lead by Moreno. Last year I had the opportunity to speak on the current and future state of neurotechnology with the National Research Council committee convened by the Department of Defense who were focused on <a href="http://www8.nationalacademies.org/cp/CommitteeView.aspx?key=48794">Military and Intelligence Methodology for Emergent Neurophysiological and Cognitive/Neural Science Research in the Next Two Decades</a>.    </p>

<p>The committee's report, "<a href="http://books.nap.edu/catalog.php?record_id=12177">Emerging Cognitive Neuroscience and Related Technologies</a>," was released yesterday, highlighting some emerging possibilities including <a href="http://www.telegraph.co.uk/news/newstopics/onthefrontline/2557025/Future-wars-to-be-fought-with-mind-drugs.html">pharmacological landmines</a>, <a href="http://blog.wired.com/wiredscience/2008/08/uncle-sam-wants.html">lie detection</a>, mind reading, cognitive enhancement and more.  In my forthcoming book, <a href="http://www.neurosociety.net/">Neurosociety</a>, which is being published by St. Martin's Press in late spring 2009, I cover many of these ideas and more. Until then, I recommend reading the report.</p>]]></description>
<link>http://brainwaves.corante.com/archives/2008/08/14/neurowarfare_futures_report_released.php</link>
<guid>http://brainwaves.corante.com/archives/2008/08/14/neurowarfare_futures_report_released.php</guid>
<category>Neurosociety</category>
<pubDate>Thu, 14 Aug 2008 10:42:25 -0500</pubDate>
</item>
<item>
<title>How Magic Fools the Brain</title>
<description><![CDATA[<p><img alt="rabbit-hat.gif" src="http://brainwaves.corante.com/rabbit-hat.gif" width="150" height="225" />Benedict Carey at the NYTimes writes an entertaining piece today, <a href="http://www.nytimes.com/2008/08/12/science/12magic.html?pagewanted=1&ei=5070&en=190e4385d2978d97&ex=1219204800&emc=eta1">While a Magician Works, the Mind Does the Tricks</a>, which dives deeper into a recent article published in <a href="http://www.nytimes.com/2008/08/12/science/12magic.html?pagewanted=1&ei=5070&en=190e4385d2978d97&ex=1219204800&emc=eta1">Nature Reviews Neuroscience</a> that highlights how magicians "take advantage of glitches in how the brain constructs a model of the outside world from moment to moment, or what we think of as objective reality."  </p>

<p>One great illusion explained in the article revolves around how our visual cortex processes stimuli has is seen in this trick by the <a href="http://johnnythompson.com/">Great Tomsoni</a>. "The magician has an assistant appear on stage in a white dress and tells the audience he will magically change the color of her dress to red. He first does this by shining a red light on her, an obvious ploy that he turns into a joke. Then the red light flicks off, the house lights go on and the now the woman is unmistakably dressed in red. The secret: In the split-second after the red light goes off, the red image lingers in the audience’s brains for about 100 milliseconds, covering the image of the woman. It’s just enough time for the woman’s white dress to be stripped away, revealing a red one underneath."</p>

<p><a href="http://www.nature.com/nrn/journal/vaop/ncurrent/full/nrn2473.html">The paper with many more explanations and links to video of a magician's performance can be found here</a>. </p>]]></description>
<link>http://brainwaves.corante.com/archives/2008/08/12/how_magic_fools_the_brain.php</link>
<guid>http://brainwaves.corante.com/archives/2008/08/12/how_magic_fools_the_brain.php</guid>
<category>Perception Shift</category>
<pubDate>Tue, 12 Aug 2008 12:38:51 -0500</pubDate>
</item>


</channel>
</rss>